Novartis New Organizational Model slide image

Novartis New Organizational Model

Revising upwards our expectations for IM core margin to low 40s mid- to long-term Innovative Medicines % Core margin 16 32 31 36 35 =4 34 Low High end of high 30s 40s 2017 2018 2019 2020 2021 Mid-term Mid- to long-term NOVARTIS NEW ORGANIZATIONAL MODEL | APRIL 04, 2022 | NOVARTIS INVESTOR PRESENTATION NOVARTIS | Reimagining Medicine
View entire presentation